These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35673115)

  • 1. Exploiting Social Media for Active Pharmacovigilance: The PVClinical Social Media Workspace.
    Kakalou C; Dimitsaki S; Dimitriadis VK; Natsiavas P
    Stud Health Technol Inform; 2022 Jun; 290():739-743. PubMed ID: 35673115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supporting Active Pharmacovigilance via IT Tools in the Clinical Setting and Beyond: Regulatory and Management Aspects.
    Natsiavas P; Gavriilidis GI; Linardaki Z; Kolangi G; Gkaliagkousi E; Zamboulis C; Jaulent MC
    Stud Health Technol Inform; 2020 Jun; 272():342-345. PubMed ID: 32604672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies.
    Koutkias VG; Lillo-Le Louët A; Jaulent MC
    Expert Opin Drug Saf; 2017 Feb; 16(2):113-124. PubMed ID: 27813420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social Media Analytics for Pharmacovigilance of Antiepileptic Drugs.
    Yahya AA; Asiri Y; Alyami I
    Comput Math Methods Med; 2022; 2022():8965280. PubMed ID: 35027943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Perspectives of Using Social Media Data to Improve Adverse Drug Reaction Reporting: A Mixed-Methods Study.
    Bulcock A; Hassan L; Giles S; Sanders C; Nenadic G; Campbell S; Dixon W
    Drug Saf; 2021 May; 44(5):553-564. PubMed ID: 33582973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing social media data for pharmacovigilance: A review.
    Sarker A; Ginn R; Nikfarjam A; O'Connor K; Smith K; Jayaraman S; Upadhaya T; Gonzalez G
    J Biomed Inform; 2015 Apr; 54():202-12. PubMed ID: 25720841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis.
    Lavertu A; Hamamsy T; Altman RB
    J Med Internet Res; 2021 Oct; 23(10):e27714. PubMed ID: 34673524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.
    Li Y; Jimeno Yepes A; Xiao C
    Drug Saf; 2020 Sep; 43(9):893-903. PubMed ID: 32385840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.
    van Stekelenborg J; Ellenius J; Maskell S; Bergvall T; Caster O; Dasgupta N; Dietrich J; Gama S; Lewis D; Newbould V; Brosch S; Pierce CE; Powell G; Ptaszyńska-Neophytou A; Wiśniewski AFZ; Tregunno P; Norén GN; Pirmohamed M
    Drug Saf; 2019 Dec; 42(12):1393-1407. PubMed ID: 31446567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Twitter as a complementary data source for pharmacovigilance.
    Lardon J; Bellet F; Aboukhamis R; Asfari H; Souvignet J; Jaulent MC; Beyens MN; Lillo-LeLouët A; Bousquet C
    Expert Opin Drug Saf; 2018 Aug; 17(8):763-774. PubMed ID: 29991282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining Adverse Drug Reactions in Social Media with Named Entity Recognition and Semantic Methods.
    Chen X; Deldossi M; Aboukhamis R; Faviez C; Dahamna B; Karapetiantz P; Guenegou-Arnoux A; Girardeau Y; Guillemin-Lanne S; Lillo-Le-Louët A; Texier N; Burgun A; Katsahian S
    Stud Health Technol Inform; 2017; 245():322-326. PubMed ID: 29295108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project.
    Caster O; Dietrich J; Kürzinger ML; Lerch M; Maskell S; Norén GN; Tcherny-Lessenot S; Vroman B; Wisniewski A; van Stekelenborg J
    Drug Saf; 2018 Dec; 41(12):1355-1369. PubMed ID: 30043385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Media Listening for Routine Post-Marketing Safety Surveillance.
    Powell GE; Seifert HA; Reblin T; Burstein PJ; Blowers J; Menius JA; Painter JL; Thomas M; Pierce CE; Rodriguez HW; Brownstein JS; Freifeld CC; Bell HG; Dasgupta N
    Drug Saf; 2016 May; 39(5):443-54. PubMed ID: 26798054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.
    Lardon J; Abdellaoui R; Bellet F; Asfari H; Souvignet J; Texier N; Jaulent MC; Beyens MN; Burgun A; Bousquet C
    J Med Internet Res; 2015 Jul; 17(7):e171. PubMed ID: 26163365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reaction detection on social media with deep linguistic features.
    Zhang Y; Cui S; Gao H
    J Biomed Inform; 2020 Jun; 106():103437. PubMed ID: 32360987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices.
    Dong F; Guo W; Liu J; Patterson TA; Hong H
    Front Public Health; 2024; 12():1392180. PubMed ID: 38716250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Adverse Drug Reactions from Patient Reports in Social Media Project: Five Major Challenges to Overcome to Operationalize Analysis and Efficiently Support Pharmacovigilance Process.
    Bousquet C; Dahamna B; Guillemin-Lanne S; Darmoni SJ; Faviez C; Huot C; Katsahian S; Leroux V; Pereira S; Richard C; Schück S; Souvignet J; Lillo-Le Louët A; Texier N
    JMIR Res Protoc; 2017 Sep; 6(9):e179. PubMed ID: 28935617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.
    Gavriilidis GI; Dimitriadis VK; Jaulent MC; Natsiavas P
    Drug Saf; 2021 Nov; 44(11):1165-1178. PubMed ID: 34674190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.